Association Between LRG and Histologic Remission in Ulcerative Colitis

Recruiting now

Conditions studied: Ulcerative Colitis in Histologic Remission

In brief

We attempt to clarify the serum leucine-rich α 2-glycoprotein (LRG) level which can predict histologic remission in ulcerative colitis patients in this study. Colonoscopy with histology will be performed when histologic remission is predicted, irrespective of symptoms or serum LRG values. Serum LRG levels are analyzed by an enzyme-linked immunosorbent assay.

Key facts

Study ID

NCT06372613

Run by

Showa Inan General Hospital

People needed

100

Starts

2024-02-25

Expected to finish

2027-12-31

Last updated by the study team

2026-04-24

Who can join

Age: 20 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• active UC patients

You may not qualify if…

• None

Where it is running

• Showa Inan General Hospital — Komagane, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.